Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate vs Budesonide in Mild to Moderate Persistent Asthma
NCT00442117Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2007
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, open-label trial of mometasone in asthma (2 arms), sponsored by Organon & Co. Primary endpoint: Forced Expiratory Volume in One Second at 12 weeks. Started Jun 2007; status: completed.
02
Drugs
mometasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00442117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442117.